Kate Bingham, managing partner at SV Life Sciences, says that biologics are "hot" right now for investors. Deal-making and greater innovation are driving the growth of the biotech sector. Report
Kate Bingham, managing partner at SV Life Sciences, says that biologics are "hot" right now for investors. Deal-making and greater innovation are driving the growth of the biotech sector. Report